Tobrex Related Published Studies
Well-designed clinical trials related to Tobrex (Tobramycin Ophthalmic)
Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. [2008.01]
Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis. [2008.01]
Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis. [2007.08]
A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis. [2007.06]
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. [2007.04]
Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis. [2007.01]
A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. [2005.09]
Well-designed clinical trials possibly related to Tobrex (Tobramycin Ophthalmic)
Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. [2008.11]
Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study. [2008.09]
Control of inflammation and prophylaxis of endophthalmitis after cataract surgery: A multicenter study. [2007.09]
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. [2007.09]
Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. [2006.02]
Other research related to Tobrex (Tobramycin Ophthalmic)
Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis. [2008.06]
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. [2007.06]
Fixed exanthema from systemic tobramycin. [2006]
Contact allergy from tobramycin eyedrops. [2005.04]
Other possibly related research studies
[Our approach in the treatment of exposed hydroxyapatite orbital implant] [2006]
Pseudomonas keratitis after laser in situ keratomileusis. [2006.03]
Traumatic late flap dehiscence and Enterobacter keratitis following LASIK. [2006.04]
Late opacification of a silicone intraocular lens caused by ophthalmic ointment. [2006.02]
Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs. [2006.03]
Controlling contagious bacterial conjunctivitis. [2006.01]
Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery. [2007.01]
Treatment of ptosis as a complication of botulinum toxin injection. [2005.03]
Fourth-generation fluoroquinolone-resistant bacterial keratitis. [2007.08]
Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. [2007.06]
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model. [2007.06]
Shewanella putrefaciens keratitis in the lamellar bed 6 years after LASIK. [2007.10]
Infectious crystalline keratopathy caused by Serratia marcescens. [2007.09]
The first case of keratitis caused by Nocardia exalbida. [2007.10]
[The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva] [2007.01]
Posttraumatic Stenotrophomonas maltophilia infectious scleritis. [2008.02]
In vitro efficacy of an ophthalmic drug combination against corneal pathogens of horses. [2008.01]
Pseudomonas keratitis associated with daily wear of silicone hydrogel contact lenses. [2008.03]
Mycobacterium chelonae keratitis in a patient with Sjogren's syndrome. [2008.03]
Microbiologic study of soft contact lenses after laser subepithelial keratectomy for myopia. [2008.01]
Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. [2008.06]
A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment. [2008.08]
Clinicobacteriological study of chronic dacryocystitis in adults. [2008.05]
Treatment of multidrug-resistant Flavobacterium indologenes keratitis with trimethoprim-sulfamethoxazole. [2008.10]
A case of polymicrobial keratitis violating an intact lens capsule. [2008.10]
[Pseudomonas aeruginosa keratitis associated with the use of last generation contact lens made of silicone hydrogel: case report] [2008.08]
Postoperative povidone-iodine prophylaxis in strabismus surgery. [2008.08]
Influence of borneol on in vitro corneal permeability and on in vivo and in vitro corneal toxicity. [2009.05]
Cutaneous allergy testing in patients suspected of an allergic reaction to eye medication. [2009]
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo] [2009.03]
Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. [2009.03]
An atypical presentation of acanthamoeba keratitis in a patient with keratoconus treated briefly with topical anesthetic. [2009.01]
Possibility of topical antioxidant treatment of cataracts: corneal penetration of pyruvate in humans. [2009]
Calotropis procera -induced keratitis. [2009.01]
Activity of antibiotics against Fusarium and Aspergillus. [2009.01]
Inhibition of corneal inflammation by the TLR4 antagonist Eritoran tetrasodium (E5564). [2009.03]
Effect of cysteine in transgenic mice on healing of corneal epithelium after excimer laser photoablation. [2008]
Mycobacterium chelonae keratitis in a patient with Sjogren's syndrome. [2008.03]
[Study of cytotoxic and antiviral effects of some eye drops] [2008]
|
